Treatment satisfaction during personalized extended interval dosing of natalizumab in patients with multiple sclerosis.

Gelissen LMY, van Hagen LA, Toorop AA, Arnoldus EPJ, Beenakker EAC, Bouvy WH, van Eijk JJJ, Eurelings M, van Genugten J, Groeneveld ON, et al.